Home › Funds › Three Bridge Wealth Advisors, LLC › ACRS
Three Bridge Wealth Advisors, LLC position in ACRS
ACLARIS THERAPEUTICS INC · Health Care
Three Bridge Wealth Advisors, LLC reported holding 714,823 shares of ACRS (ACLARIS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3.8M, representing 0.80% of its reported portfolio and ranking #22 among its reported holdings. Three Bridge Wealth Advisors, LLC has disclosed ACRS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Three Bridge Wealth Advisors, LLC's ACRS position evolved
Three Bridge Wealth Advisors, LLC first disclosed a stake in ACRS in Q3 2025 at 714,823 shares (US$1.4M). The position peaked in Q2 2026 at 714,823 shares, worth US$3.8M. Across 5 filings, Three Bridge Wealth Advisors, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 714,823 shares valued at US$3.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 714.82K | $1.36M | New |
| Q4 2025 | 714.82K | $2.15M | Hold |
| Q1 2026 | 714.82K | $2.68M | Hold |
| Q2 2026 | 714.82K | $3.78M | Hold |
| Q3 2026 | 714.82K | $3.76M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ACRS and 13F data
ACRS (ACLARIS THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in ACRS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$67.3M), BML Capital Management, LLC (US$57.6M), Deep Track Capital, LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ACRS
- RA CAPITAL MANAGEMENT, L.P. 12.72M sh · $67.30M · Q2 2026
- BML Capital Management, LLC 10.96M sh · $57.62M · Q3 2026
- Deep Track Capital, LP 9.35M sh · $49.44M · Q2 2026
- Vivo Capital, LLC 6.69M sh · $35.21M · Q3 2026
- Frazier Life Sciences Management, L.P. 4.93M sh · $26.06M · Q2 2026
- Rock Springs Capital Management LP 4.33M sh · $22.91M · Q2 2026
- Decheng Capital LLC 4.04M sh · $21.38M · Q2 2026
- Jones Hill Capital LP 2.50M sh · $13.17M · Q3 2026
- Kalehua Capital Management LLC 1.83M sh · $9.64M · Q3 2026
- Palo Alto Investors LP 1.61M sh · $8.54M · Q2 2026
- MPM BioImpact LLC 1.04M sh · $5.51M · Q2 2026
- Aldebaran Capital, LLC 936.18K sh · $4.92M · Q3 2026
More on Three Bridge Wealth Advisors, LLC
FAQ
How long has Three Bridge Wealth Advisors, LLC held ACRS?
Three Bridge Wealth Advisors, LLC has disclosed ACRS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Three Bridge Wealth Advisors, LLC's current position in ACRS?
As of Q3 2026, Three Bridge Wealth Advisors, LLC holds 714.82K shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $3.76M, representing 0.80% of its reported portfolio and ranking #22.
Has Three Bridge Wealth Advisors, LLC been buying or selling ACRS?
In the latest 13F filing (Q3 2026), Three Bridge Wealth Advisors, LLC held unchanged its position in ACRS. The position peaked in Q2 2026 at 714.82K shares.
Which other funds hold ACRS?
Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.